DOCSLIB.ORG

Mouse Setmar Conditional Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Setmar Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Setmar Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Setmar conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Setmar gene (NCBI Reference Sequence: NM_178391 ; Ensembl: ENSMUSG00000034639 ) is located on Mouse chromosome 6. 2 exons are identified, with the ATG start codon in exon 1 and the TAG stop codon in exon 2 (Transcript: ENSMUST00000049246). Exon 2 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Setmar gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-93D20 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 2 covers 82.85% of the coding region. Start codon is in exon 1, and stop codon is in exon 2. The size of intron 1 for 5'-loxP site insertion: 10466 bp. The size of effective cKO region: ~2167 bp. The cKO region does not have any other known gene. Page 1 of 7 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Setmar Homology arm cKO region loxP site Page 2 of 7 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(7268bp) | A(30.02% 2182) | C(21.84% 1587) | T(27.79% 2020) | G(20.35% 1479) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 7 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr6 + 108072457 108075456 3000 browser details YourSeq 77 2159 2401 3000 89.8% chr5 + 131175804 131176046 243 browser details YourSeq 66 2236 2369 3000 72.0% chr7 + 144172688 144172819 132 browser details YourSeq 62 2238 2427 3000 91.9% chr17 - 84503163 84503353 191 browser details YourSeq 59 2342 2423 3000 94.1% chr9 - 111144419 111144505 87 browser details YourSeq 59 2342 2423 3000 94.1% chr5 - 39191300 39191386 87 browser details YourSeq 59 2342 2423 3000 94.1% chr17 - 68503145 68503231 87 browser details YourSeq 56 2237 2421 3000 87.4% chr6 + 134562819 134562998 180 browser details YourSeq 55 2236 2414 3000 93.8% chr1 - 121354013 121354206 194 browser details YourSeq 55 2234 2414 3000 84.7% chr17 + 43514260 43514436 177 browser details YourSeq 51 2330 2404 3000 88.1% chr6 - 50060300 50060375 76 browser details YourSeq 50 2236 2397 3000 86.3% chr15 + 3254575 3254733 159 browser details YourSeq 49 1486 1727 3000 94.6% chr7 + 122183515 122183758 244 browser details YourSeq 48 2236 2399 3000 79.7% chr6 + 119827540 119827691 152 browser details YourSeq 45 2350 2422 3000 96.0% chr19 + 27747451 27747529 79 browser details YourSeq 45 2238 2399 3000 88.7% chr16 + 58248601 58248761 161 browser details YourSeq 45 2335 2399 3000 86.6% chr11 + 65610154 65610216 63 browser details YourSeq 44 2842 2951 3000 78.5% chr11 - 40511846 40511957 112 browser details YourSeq 44 2239 2374 3000 66.2% chr2 + 122699496 122699631 136 browser details YourSeq 42 1672 1726 3000 92.0% chr19 + 23716556 23716611 56 Note: The 3000 bp section upstream of Exon 2 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr6 + 108076475 108079474 3000 browser details YourSeq 111 1940 2138 3000 83.3% chr11 - 101944685 101944900 216 browser details YourSeq 102 1914 2193 3000 87.7% chr12 + 81789891 81790247 357 browser details YourSeq 80 2021 2166 3000 90.9% chr2 - 131962524 131962784 261 browser details YourSeq 80 2016 2166 3000 85.8% chr18 + 46400546 46400696 151 browser details YourSeq 77 1923 2130 3000 89.8% chr9 - 54966341 54966567 227 browser details YourSeq 76 1925 2140 3000 88.0% chr12 + 28720290 28720510 221 browser details YourSeq 67 1919 2136 3000 92.5% chr4 - 53064814 53065080 267 browser details YourSeq 67 1914 2136 3000 92.6% chr10 + 72579934 72580175 242 browser details YourSeq 62 2018 2173 3000 87.4% chr18 - 34894933 34895087 155 browser details YourSeq 62 1887 2160 3000 92.0% chr2 + 84863827 84864225 399 browser details YourSeq 60 2574 2662 3000 86.8% chr15 - 101281300 101281397 98 browser details YourSeq 58 2024 2188 3000 92.7% chr9 - 115146171 115146342 172 browser details YourSeq 57 1948 2051 3000 90.3% chr9 - 87244990 87245109 120 browser details YourSeq 57 2580 2740 3000 79.0% chr11 + 88854670 88854819 150 browser details YourSeq 56 1919 2143 3000 89.1% chr7 + 7985459 7985726 268 browser details YourSeq 56 2035 2166 3000 86.8% chr13 + 56497573 56497702 130 browser details YourSeq 55 1939 2142 3000 96.7% chr6 - 57549550 57549843 294 browser details YourSeq 55 2022 2140 3000 87.7% chr16 - 30143669 30143789 121 browser details YourSeq 55 2047 2160 3000 84.0% chr8 + 122528416 122528528 113 Note: The 3000 bp section downstream of Exon 2 is BLAT searched against the genome. No significant similarity is found. Page 4 of 7 https://www.alphaknockout.com Gene and protein information: Setmar SET domain without mariner transposase fusion [ Mus musculus (house mouse) ] Gene ID: 74729, updated on 12-Aug-2019 Gene summary Official Symbol Setmar provided by MGI Official Full Name SET domain without mariner transposase fusion provided by MGI Primary source MGI:MGI:1921979 See related Ensembl:ENSMUSG00000034639 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as Etet2; 5830404F24Rik Summary This gene encodes a histone-lysine N-methyltransferase that may be involved in the methylation of histone H3. In Expression anthropoid primates this gene is a fusion gene of a SET histone-lysine N-methyltransferase and a mariner (MAR) family transposase. In all other species this gene contains only the SET domain. [provided by RefSeq, Jan 2013] Orthologs Ubiquitous expression in bladder adult (RPKM 2.7), frontal lobe adult (RPKM 1.9) and 28 other tissues See more human all Genomic context Location: 6; 6 E1 See Setmar in Genome Data Viewer Exon count: 3 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 6 NC_000072.6 (108065045..108077127) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 6 NC_000072.5 (108015040..108027114) Chromosome 6 - NC_000072.6 Page 5 of 7 https://www.alphaknockout.com Transcript information: This gene has 2 transcripts Gene: Setmar ENSMUSG00000034639 Description SET domain without mariner transposase fusion [Source:MGI Symbol;Acc:MGI:1921979] Gene Synonyms 5830404F24Rik, Etet2 Location Chromosome 6: 108,065,045-108,077,122 forward strand. GRCm38:CM000999.2 About this gene This gene has 2 transcripts (splice variants), 177 orthologues, 21 paralogues, is a member of 1 Ensembl protein family and is associated with 9 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Setmar- ENSMUST00000049246.6 1612 309aa ENSMUSP00000048225.5 Protein coding CCDS51867 Q80UJ9 TSL:1 201 GENCODE basic APPRIS P1 Setmar- ENSMUST00000138140.2 1748 60aa ENSMUSP00000145263.1 Nonsense mediated - A0A0N4SVW0 TSL:3 202 decay 32.08 kb Forward strand 108.06Mb 108.07Mb 108.08Mb Genes (Comprehensive set... Setmar-201 >protein coding Setmar-202 >nonsense mediated decay Contigs AC153916.2 > Regulatory Build 108.06Mb 108.07Mb 108.08Mb Reverse strand 32.08 kb Regulation Legend CTCF Open Chromatin Promoter Promoter Flank Transcription Factor Binding Site Gene Legend Protein Coding merged Ensembl/Havana Non-Protein Coding processed transcript Page 6 of 7 https://www.alphaknockout.com Transcript: ENSMUST00000049246 12.08 kb Forward strand Setmar-201 >protein coding ENSMUSP00000048... Low complexity (Seg) Superfamily SSF82199 SMART Pre-SET domain SET domain Pfam Pre-SET domain SET domain PROSITE profiles Pre-SET domain SET domain Post-SET domain PANTHER PTHR45660:SF13 PTHR45660 Gene3D 2.170.270.10 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant synonymous variant Scale bar 0 40 80 120 160 200 240 309 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 7 of 7.
Load more

Recommended publications
  • Whole-Genome Microarray Detects Deletions and Loss of Heterozygosity of Chromosome 3 Occurring Exclusively in Metastasizing Uveal Melanoma
    Anatomy and Pathology Whole-Genome Microarray Detects Deletions and Loss of Heterozygosity of Chromosome 3 Occurring Exclusively in Metastasizing Uveal Melanoma Sarah L. Lake,1 Sarah E. Coupland,1 Azzam F. G. Taktak,2 and Bertil E. Damato3 PURPOSE. To detect deletions and loss of heterozygosity of disease is fatal in 92% of patients within 2 years of diagnosis. chromosome 3 in a rare subset of fatal, disomy 3 uveal mela- Clinical and histopathologic risk factors for UM metastasis noma (UM), undetectable by fluorescence in situ hybridization include large basal tumor diameter (LBD), ciliary body involve- (FISH). ment, epithelioid cytomorphology, extracellular matrix peri- ϩ ETHODS odic acid-Schiff-positive (PAS ) loops, and high mitotic M . Multiplex ligation-dependent probe amplification 3,4 5 (MLPA) with the P027 UM assay was performed on formalin- count. Prescher et al. showed that a nonrandom genetic fixed, paraffin-embedded (FFPE) whole tumor sections from 19 change, monosomy 3, correlates strongly with metastatic death, and the correlation has since been confirmed by several disomy 3 metastasizing UMs. Whole-genome microarray analy- 3,6–10 ses using a single-nucleotide polymorphism microarray (aSNP) groups. Consequently, fluorescence in situ hybridization were performed on frozen tissue samples from four fatal dis- (FISH) detection of chromosome 3 using a centromeric probe omy 3 metastasizing UMs and three disomy 3 tumors with Ͼ5 became routine practice for UM prognostication; however, 5% years’ metastasis-free survival. to 20% of disomy 3 UM patients unexpectedly develop metas- tases.11 Attempts have therefore been made to identify the RESULTS. Two metastasizing UMs that had been classified as minimal region(s) of deletion on chromosome 3.12–15 Despite disomy 3 by FISH analysis of a small tumor sample were found these studies, little progress has been made in defining the key on MLPA analysis to show monosomy 3.
    [Show full text]
  • SETMAR Antibody
    Product Datasheet SETMAR Antibody Catalog No: #43086 Orders: [email protected] Description Support: [email protected] Product Name SETMAR Antibody Host Species Rabbit Clonality Polyclonal Purification Antigen affinity purification. Applications WB IHC Species Reactivity Hu Specificity The antibody detects endogenous levels of total SETMAR protein. Immunogen Type protein Immunogen Description Fusion protein of human SETMAR Target Name SETMAR Other Names Mar1; HsMar1; METNASE Accession No. Swiss-Prot#: Q53H47Gene ID: 6419 Calculated MW 78kd Concentration 1mg/ml Formulation Rabbit IgG in pH7.4 PBS, 0.05% NaN3, 40% Glycerol. Storage Store at -20°C Application Details Western blotting: 1:200-1:1000 Immunohistochemistry: 1:20-1:100 Images Gel: 6%SDS-PAGE Lysate: 40 µg Lane: Jurkat cell Primary antibody: 1/400 dilution Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution Exposure time: 30 seconds Address: 8400 Baltimore Ave., Suite 302, College Park, MD 20740, USA http://www.sabbiotech.com 1 Immunohistochemical analysis of paraffin-embedded Human liver cancer tissue using #43086 at dilution 1/20. Immunohistochemical analysis of paraffin-embedded Human thyroid cancer tissue using #43086 at dilution 1/20. Background This gene encodes a fusion protein that contains an N-terminal histone-lysine N-methyltransferase domain and a C-terminal mariner transposase domain. The encoded protein binds DNA and functions in DNA repair activities including non-homologous end joining and double strand break repair. The SET domain portion of this protein specifically methylates histone H3 lysines 4 and 36. This gene exists as a fusion gene only in anthropoid primates, other organisms lack mariner transposase domain. Note: This product is for in vitro research use only and is not intended for use in humans or animals.
    [Show full text]
  • Birth of a Chimeric Primate Gene by Capture of the Transposase Gene
    Birth of a chimeric primate gene by capture of the SEE COMMENTARY transposase gene from a mobile element Richard Cordaux*, Swalpa Udit†, Mark A. Batzer*, and Ce´ dric Feschotte†‡ *Department of Biological Sciences, Biological Computation and Visualization Center, Center for BioModular Multi-Scale Systems, Louisiana State University, 202 Life Sciences Building, Baton Rouge, LA 70803; and †Department of Biology, University of Texas, Arlington, TX 76019 Edited by Susan R. Wessler, University of Georgia, Athens, GA, and approved March 27, 2006 (received for review February 10, 2006) The emergence of new genes and functions is of central impor- SETMAR transcript, which consists of these three exons, is tance to the evolution of species. The contribution of various types predicted to encode a protein of 671 amino acids and is of duplications to genetic innovation has been extensively inves- supported by 48 human cDNA clones from 18 different normal tigated. Less understood is the creation of new genes by recycling and͞or cancerous tissues (Table 1, which is published as sup- of coding material from selfish mobile genetic elements. To inves- porting information on the PNAS web site; refs. 14 and 15). tigate this process, we reconstructed the evolutionary history of These data suggest that the SETMAR protein is broadly ex- SETMAR, a new primate chimeric gene resulting from fusion of a pressed and has an important, yet unknown, function in human. SET histone methyltransferase gene to the transposase gene of a Recently, it was shown that the SET domain of the SETMAR mobile element. We show that the transposase gene was recruited protein exhibits histone methyltransferase activity (15), as do all as part of SETMAR 40–58 million years ago, after the insertion of known SET domains (16, 17).
    [Show full text]
  • 2010 Fallfinal.Pdf
    Bruker AXS 3 Year Warranty on IµS X8 PROSPECTOR High Performance, Low Maintenance The X8 PROSPECTOR is an exceptionally low maintenance x-ray system designed to simplify crystal screening and data collection. The X8 PROSPECTOR has the reli- ability, speed and performance to make any structural biology lab more productive. Ultra-reliable IµS source with QUAZAR MX optics for a surprisingly high intensity Taperless CCD for ultimate detector sensitivity and speed Low maintenance, low cost of ownership - air-cooled source Crystallography think forward www.bruker-axs.com American Crystallographic Association The cover image was adapted from a slide shown by Gerald Stubbs in session 7.09 Fibril-forming Pathological Pep- ACA RefleXions tides: Prions, Amyloids & "Friends". Fall, 2010 See page 8 for a more complete description. ACA HOME PAGE: www.AmerCrystalAssn.org Table of Contents 3 President’s Column 5 Highlights of Council meetings in Chicago 6-8 Awards & News 8 On the Cover 9-11 Dick van der Helm (1933-2010) 12-15 David H. Templeton (1920-2010) 15 Lachlan M. D. Cranswick (1969-2010) 16 Lodovico Riva Di Sanseverino (1939-2010) 17 Gordon Smith (1928-2010) 17 Contributors to this issue 18 Late-breaking news; calls for award nominations, nominations for ACA offices in 2012; summer school proposals; pleas for Opinion column volunteer and for Art in Crystallography entries. 19-57 2010 ACA meeting in Chicago: poster awards; photos of attendees, reports from session chairs, and images the speakers used in their talks. 38 Index of advertisers 59 Corporate Members 61 ISC 2010 in Granada 63 2011 ACA meeting in New Orleans 64 Calendar of Meetings Contributions to ACA RefleXions may be sent to either of the Editors: Please address matters pertaining to advertisements, membership inquiries, or use of the ACA mailing list to: Connie (Chidester) Rajnak ........................
    [Show full text]
  • A Role for Setmar in Gene Regulation
    A ROLE FOR SETMAR IN GENE REGULATION: INSIGHTS FROM STRUCTURAL ANALYSIS OF THE DNA-BINDING DOMAIN IN COMPLEX WITH DNA Qiujia Chen Submitted to the faculty of the University Graduate School in partial fulfillment of the requirements for the degree Doctor of Philosophy in the Department of Biochemistry and Molecular Biology Indiana University August 2016 Accepted by the Graduate Faculty, Indiana University, in partial fulfillment of the requirements for the degree of Doctor of Philosophy. ___________________________ Millie M. Georgiadis, Ph. D., Chair ___________________________ Thomas D. Hurley, Ph. D. Doctoral Committee ___________________________ Ronald C. Wek, Ph. D. June 30, 2016 ___________________________ John J. Turchi, Ph. D. ___________________________ Mark R. Kelley, Ph. D. ii DEDICATION This thesis is dedicated to my parents Chuhui and Xuanna. Thank you for giving me the best education you could and great support. To my brother Jiamin, sister-in-law Xiaoqiong, and my niece Yuhan, for helping me survive all the stress. I would like to dedicate this thesis to Dr. Jinsong Liu, who opened the door for me to the intriguing world of X-ray crystallography and structural biology. Special dedication of this thesis must be given to Dr. Millie M. Georgiadis, a very talented and inspiring scientific mentor and advisor, for her patience, enthusiasm, and encouragement throughout this project. iii ACKNOWLEDGEMENTS Firstly, I would like to express deepest appreciation to my advisor, Professor Millie M. Georgiadis, for her continuous support of my Ph.D research work, for her motivation, patience, and immense knowledge. Her excitement in regard to protein-DNA crystallography helped me in all the time of research and writing of this thesis.
    [Show full text]
  • A Single Genetic Locus Associated with Pediatric Fractures: a Genome-Wide Association Study on 3,230 Patients
    1716 EXPERIMENTAL AND THERAPEUTIC MEDICINE 20: 1716-1724, 2020 A single genetic locus associated with pediatric fractures: A genome-wide association study on 3,230 patients ROOPE PARVIAINEN1, SINI SKARP2,3, LINDA KORHONEN1, WILLY SERLO1, MINNA MÄNNIKKÖ2 ��� JUHA-JAAKKO SINIKUMPU1 1D�p���m��� �� C������� ��� A����������, O��� C�������� F������� ��� Sp���� I�j��y S���y, R������� U��� ��� P���������, P�������� N�������y, P�������� Surgery, C���� P�y������y, D��m������y, C������� G�������, O��������� ��� Gy�������y, O����������y������y ��� Op�����m����y (PEDEGO), O��� M������ R������� C����� (MRC), U��������y �� O��� ��� O��� U��������y H��p����, FI-90029 O���; 2N������� F������ B���� C�����, F�����y �� M�������, U��������y �� O���; 3C����� ��� L��� C����� H����� R�������, F�����y �� M�������, U��������y �� O���, FI-90014 O���, F������ Received July 13, 2019; Accepted April 29, 2020 DOI: 10.3892/etm.2020.8885 Abstract. The�� understanding������������� ��of the��� biological���������� and��� environ�������- RNA 1 (PROSER2-AS1) and PROSER2, thus suggesting that mental risk factors of fractures in pediatrics is limited. Previous these m�y be novel candidate genes associated with the risk of studies have reported that fractures involve heritable traits, but pediatric fractures. the genetic factors contributing to the risk of fractures remain elusive. Furthermore, genetic influences specific to immature Introduction bone have not been thoroughly studied. Therefore, the aim of the present study was to identify genetic variations that are The incidence of fractures is highest �mong the young and associated with fractures in early childhood. The present study older p�pulations (1). O� note, fractures in pediatric patients used � prospective Northern Finland Birth Cohort (year 1986; are common injuries that result in pain, as well as short‑ and �=9,432).
    [Show full text]
  • Anti-SETMAR-Antibody Pack Size
    TECHNICAL DATA SHEET Cat No: Kab07773 Product Particulars: anti-SETMAR-antibody Pack Size: 100μg Pack Size: Pack Size: 100μg Purify: Immunogen affinity purified Host: Rabbit Isotype: IgG Storage: PBS with 0.02% sodium azide and 50% glycerol pH 7.3 , -20Ԩ for 24 months (Avoid repeated freeze / thaw cycles.) Background (Function): Protein derived from the fusion of a methylase with the transposase of an Hsmar1 transposon that plays a role in DNA double-strand break repair, stalled replication fork restart and DNA integration. DNA-binding protein, it is indirectly recruited to sites of DNA damage through protein-protein interactions. Has also kept a sequence-specific DNA-binding activity recognizing the 19- mer core of the 5'-terminal inverted repeats (TIRs) of the Hsmar1 element and displays a DNA nicking and end joining activity (PubMed:16332963, PubMed:16672366, PubMed:17877369, PubMed:17403897, PubMed:18263876, PubMed:22231448, PubMed:24573677, PubMed:20521842). In parallel, has a histone methyltransferase activity and methylates 'Lys-4' and 'Lys-36' of histone H3. Specifically mediates dimethylation of H3 'Lys-36' at sites of DNA double-strand break and may recruit proteins required for efficient DSB repair through non-homologous end-joining (PubMed:16332963, PubMed:21187428, PubMed:22231448). Also regulates replication fork processing, promoting replication fork restart and regulating DNA decatenation through stimulation of the topoisomerase activity of TOP2A (PubMed:18790802, PubMed:20457750). Immunogen: SET domain and mariner transposase fusion gene Synonyms: Calculated MW: Uniprot ID: Q53H47 Specificity: Human Tested Application: ELISA,WB,IP Recommended Dilution: Gene ID: 6419 Gene Location: Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE" OUR KINESISDX COMMITMENT : GUARANTEED QUALITY WITH EXPERT TECHNICAL SUPPORT .
    [Show full text]
  • Evolutionary Tinkering with Transposable Elements
    COMMENTARY Evolutionary tinkering with transposable elements I. King Jordan* National Center for Biotechnology Information, National Institutes of Health, Bethesda, MD 20894 t was almost 30 years ago when with to create novel forms. Indeed, de- Franc¸oisJacob declared that evolu- spite the early notion of TEs as being tionary innovation (the emergence strictly selfish (parasitic) elements that of novel form and function over serve no function for their hosts (7), Itime) occurred primarily via a process there now exist numerous examples of of ‘‘tinkering’’ (1). By tinkering, Jacob formerly mobile TE sequences that have essentially meant the creation of novelty been ‘‘domesticated’’ (8) to serve some through random combinations of pre- functional role for the host genomes in existing forms. Two fundamental and which they reside (9, 10). However, countervailing notions are implicit in there is still a relative paucity of de- this view of evolution: optimality versus tailed studies that address both the evo- constraint. Were evolution to perform lutionary dynamics of TE-derived host optimally, a more apt metaphor might genes as well as the functional roles of be that of an engineer. An engineer the proteins that they encode. The work works according to a plan, with a pre- of Cordaux et al. (3) on the SETMAR cise goal for the desired end, and uses gene represents an important step to- material designed specifically toward ward alleviating this knowledge gap. that end. Evolution, on the other hand, SETMAR, originally discovered by must work without the benefit of fore- Robertson and Zumpano (11), is a chi- sight and is subject to very real con- meric gene made up of a SET histone straints with respect to the material at methyltransferase transcript fused to the its disposal; as such, evolutionary biol- transposase domain of a formerly mo- ogy is replete with examples of subopti- bile TE sequence.
    [Show full text]
  • Mutational and Functional Analyses of Kabuki Syndrome Genes Demonstrate Critical Roles in Craniofacial, Heart and Brain Developm
    MUTATIONAL AND FUNCTIONAL ANALYSES OF KABUKI SYNDROME GENES DEMONSTRATE CRITICAL ROLES IN CRANIOFACIAL, HEART AND BRAIN DEVELOPMENT By PETER MARCEL VAN LAARHOVEN B.S., University of California, Los Angeles, 2008 A thesis submitted to the Faculty of the Graduate School of the University of Colorado in partial fulfillment of the requirements for the degree of Doctor of Philosophy Human Medical Genetics and Genomics Program 2015 This thesis for the Doctor of Philosophy degree by Peter Marcel Van Laarhoven has been approved for the Human Medical Genetics and Genomics Program by Kristin B. Artinger, Chair Tamim H. Shaikh, Advisor Bruce H. Appel Paul C. Megee Jay R. Hesselberth Date _01/27/2015_ ii Van Laarhoven, Peter Marcel (Ph.D., Human Medical Genetics and Genomics) Mutational and Functional Analyses of Kabuki Syndrome Genes Demonstrate Critical Roles in Craniofacial, Heart, and Brain Development Thesis directed by Associate Professor Tamim H. Shaikh. ABSTRACT Kabuki syndrome (KS) is a rare multiple congenital anomaly syndrome characterized by distinctive facial features, global developmental delay, intellectual disability, and cardiovascular and musculoskeletal abnormalities. Mutations in KMT2D have been identified in a majority of KS patients, and mutations in KDM6A have been identified as a rare cause of KS. Fifty-seven individuals clinically diagnosed with KS were analyzed for mutations in KMT2D and KDM6A, 17 by the group that implicated KMT2D and forty by ourselves. Putative pathogenic mutations were detected in KMT2D in 27 subjects and KDM6A in 4 subjects. Observed mutations included single nucleotide variations and indels leading to frameshifts, nonsense, missense or splice site alterations in both genes.
    [Show full text]
  • Analysis of Mammalian Gene Function Through Broad-Based Phenotypic
    ARTICLES Analysis of mammalian gene function through broad-based phenotypic screens across a consortium of mouse clinics The function of the majority of genes in the mouse and human genomes remains unknown. The mouse embryonic stem cell knockout resource provides a basis for the characterization of relationships between genes and phenotypes. The EUMODIC consortium developed and validated robust methodologies for the broad-based phenotyping of knockouts through a pipeline comprising 20 disease-oriented platforms. We developed new statistical methods for pipeline design and data analysis aimed at detecting reproducible phenotypes with high power. We acquired phenotype data from 449 mutant alleles, representing 320 unique genes, of which half had no previous functional annotation. We captured data from over 27,000 mice, finding that 83% of the mutant lines are phenodeviant, with 65% demonstrating pleiotropy. Surprisingly, we found significant differences in phenotype annotation according to zygosity. New phenotypes were uncovered for many genes with previously unknown function, providing a powerful basis for hypothesis generation and further investigation in diverse systems. Phenotypic annotations of knockout mutants have been generated for (EMPReSS) database10 catalogs the standard operating procedures about a third of the genes in the mouse genome1. However, the way in (SOPs) that were developed, including operational details and the which the phenotype is screened is often dependent on the expertise and parameters measured. More recently, a major single-center effort interests of the investigator, and in only a few cases has a broad-based to analyze several hundred knockout lines through a phenotyping assessment of phenotype been undertaken that encompassed the analy- pipeline has illuminated the pleiotropy that can be found and the sis of developmental, biochemical, physiological and organ systems2–4.
    [Show full text]
  • Epigenome Alterations in Aortic Valve Stenosis and Its Related Left
    Gošev et al. Clinical Epigenetics (2017) 9:106 DOI 10.1186/s13148-017-0406-7 REVIEW Open Access Epigenome alterations in aortic valve stenosis and its related left ventricular hypertrophy Igor Gošev1, Martina Zeljko2, Željko Đurić3, Ivana Nikolić4, Milorad Gošev5, Sanja Ivčević6, Dino Bešić7, Zoran Legčević7 and Frane Paić7* Abstract Aortic valve stenosis is the most common cardiac valve disease, and with current trends in the population demographics, its prevalence is likely to rise, thus posing a major health and economic burden facing the worldwide societies. Over the past decade, it has become more than clear that our traditional genetic views do not sufficiently explain the well-known link between AS, proatherogenic risk factors, flow-induced mechanical forces, and disease-prone environmental influences. Recent breakthroughs in the field of epigenetics offer us a new perspective on gene regulation, which has broadened our perspective on etiology of aortic stenosis and other aortic valve diseases. Since all known epigenetic marks are potentially reversible this perspective is especially exciting given the potential for development of successful and non-invasive therapeutic intervention and reprogramming of cells at the epigenetic level even in the early stages of disease progression. This review will examine the known relationships between four major epigenetic mechanisms: DNA methylation, posttranslational histone modification, ATP-dependent chromatin remodeling, and non-coding regulatory RNAs, and initiation and progression of AS. Numerous profiling and functional studies indicate that they could contribute to endothelial dysfunctions, disease-prone activation of monocyte-macrophage and circulatory osteoprogenitor cells and activation and osteogenic transdifferentiation of aortic valve interstitial cells, thus leading to valvular inflammation, fibrosis, and calcification, and to pressure overload-induced maladaptive myocardial remodeling and left ventricular hypertrophy.
    [Show full text]
  • Anti-SETMAR Recombinant Mouse Monoclonal Antibody
    Anti-SETMAR Recombinant Mouse Monoclonal Antibody Publication Number: MAN0007028 Rev. 1.00 Catalog Number: 730059 Store at 2°C to 8°C (short-term), or –20°C (long-term) Clonality: Monoclonal Host/Class: Mouse IgG1 Concentration: 0.5 mg/mL Reactivity: Human SETMAR Quantity: 100 µg Predicted Reactivity: Human Volume: 200 µL Product Description Storage Buffer SETMAR is a histone methyltransferase that is involved in Phosphate buffered saline (PBS) with 0.09% sodium azide. epigenetic transcriptional activation by methylating lysine Caution: Sodium azide is extremely toxic and may react with lead residues on histone H3 tails. SETMAR has in vivo end joining and copper plumbing to form highly explosive metal azides. activity, and may mediate the genomic integration of foreign Properly dispose of solutions containing sodium azide. Read the DNA. Safety Data Sheets (SDSs) and follow the handling instructions. This antibody was developed against a fully folded protein Wear appropriate protective eyewear, clothing and gloves. SDSs domain, so it does not show good reactivity against denatured are available at www.lifetechnologies.com/support. proteins, and may not work in western blot applications. Product Specifications Immunogen: Folded protein domain corresponding to amino acids 397–671, (Transposase domains) of human SETMAR Alternate Names: SETMAR Apparent MW: 76.7 kDa Gene ID: 6419 Protein Accession No.: Q53H47 Sequence Identity: Human Lot: See product label Product Applications Test Application Species Concentration Material Immunoprecipitation Human HEK293 2 µg per IP + Mass Spectrometry Storage and Handling Store the antibody at 2°C to 8°C for up to 1 month, –20°C for long-term storage.
    [Show full text]